Literature DB >> 30864244

Peripheral blood telomere alterations in ground glass opacity (GGO) lesions may suggest malignancy.

Matthew Koslow1, David Shitrit2,3, Lilach Israeli-Shani2,3, Orit Uziel3,4, Einat Beery4, Alexandra Osadchy5, Yael Refaely6, Gali Epstein Shochet2,3, Aliza Amiel3,7.   

Abstract

A ground glass opacity (GGO) lung lesion may represent early stage adenocarcinoma, which has an excellent prognosis upon prompt surgical resection. However, GGO lesions have broad differential diagnoses, including both benign and malignant lesions. Our objective was to study telomere length and telomerase activity in patients with suspected lung cancer in which GGO was the predominant radiographic feature. Knowledge of telomere biology may help distinguish malignant from benign radiographic lesions and guide risk assessment of these lesions. Peripheral blood samples were taken from 22 patients with suspected adenocarcinoma with the GGO radiographic presentation. Multidisciplinary discussion confirmed the need for surgery in all cases. We used an age and gender-matched group without known lung disease as a control. Telomere length and aggregates were assessed by quantitative fluorescence in situ hybridization (QFISH) and quantitative PCR. Cell senescence was evaluated by senescence-associated heterochromatin foci. Subjects with GGO lesions had a higher percentage of lymphocytes with shorter telomeres (Q-FISH, P = 0.003). Furthermore, relative telomere length was also reduced among the GGO cases (qPCR, P < 0.05). Increased senescence was observed in the GGO group compared to controls (P < 0.001), with significant correlation between the senescence-associated heterochromatin foci and aggregate formation (r = -0.7 and r = -0.44 for cases and controls, respectively). In conclusion, patients with resectable early adenocarcinoma demonstrate abnormal telomere length and cell senescence in peripheral blood leukocytes compared to control subjects. Abnormal telomere biology in the peripheral blood may increase suspicion of early adenocarcinoma among patients with GGO lesions.
© 2019 The Authors. Thoracic Cancer published by China Lung Oncology Group and John Wiley & Sons Australia, Ltd.

Entities:  

Keywords:  Adenocarcinoma; GGO; blood marker; senescence; telomere

Mesh:

Year:  2019        PMID: 30864244      PMCID: PMC6449235          DOI: 10.1111/1759-7714.13026

Source DB:  PubMed          Journal:  Thorac Cancer        ISSN: 1759-7706            Impact factor:   3.500


  34 in total

Review 1.  Bronchioloalveolar carcinoma of the lung 3 centimeters or less in diameter: a prognostic assessment.

Authors:  Hiroyuki Sakurai; Yoh Dobashi; Eiki Mizutani; Hirochika Matsubara; Shoji Suzuki; Kunio Takano; Shunya Shindo; Masahiko Matsumoto
Journal:  Ann Thorac Surg       Date:  2004-11       Impact factor: 4.330

2.  Telomere aggregates in non-Hodgkin lymphoma patients at different disease stages.

Authors:  L Goldberg-Bittman; Y Kitay-Cohen; M Quitt; R Hadary; M D Fejgin; M Yukla; A Amiel
Journal:  Cancer Genet Cytogenet       Date:  2008-07-15

3.  Telomeres in trisomy 21 amniocytes.

Authors:  R Sukenik-Halevy; T Biron-Shental; R Sharony; M D Fejgin; A Amiel
Journal:  Cytogenet Genome Res       Date:  2011-07-06       Impact factor: 1.636

4.  High-resolution CT analysis of small peripheral lung adenocarcinomas revealed on screening helical CT.

Authors:  Z G Yang; S Sone; S Takashima; F Li; T Honda; Y Maruyama; M Hasegawa; S Kawakami
Journal:  AJR Am J Roentgenol       Date:  2001-06       Impact factor: 3.959

5.  Results of wedge resection for focal bronchioloalveolar carcinoma showing pure ground-glass attenuation on computed tomography.

Authors:  Shun-ichi Watanabe; Toshio Watanabe; Kazunori Arai; Takahiko Kasai; Joji Haratake; Hiroshi Urayama
Journal:  Ann Thorac Surg       Date:  2002-04       Impact factor: 4.330

6.  Primary Care Providers and a System Problem: A Qualitative Study of Clinicians Caring for Patients With Incidental Pulmonary Nodules.

Authors:  Sara E Golden; Renda Soylemez Wiener; Donald Sullivan; Linda Ganzini; Christopher G Slatore
Journal:  Chest       Date:  2015-12       Impact factor: 9.410

7.  Telomeres are shorter in placentas from pregnancies with uncontrolled diabetes.

Authors:  T Biron-Shental; R Sukenik-Halevy; H Naboani; M Liberman; R Kats; A Amiel
Journal:  Placenta       Date:  2014-11-25       Impact factor: 3.481

8.  Telomere length in Hepatitis C.

Authors:  Y Kitay-Cohen; L Goldberg-Bittman; R Hadary; M D Fejgin; A Amiel
Journal:  Cancer Genet Cytogenet       Date:  2008-11

9.  Invasive size is an independent predictor of survival in pulmonary adenocarcinoma.

Authors:  Alain C Borczuk; Fang Qian; Angeliki Kazeros; Jennifer Eleazar; Adel Assaad; Joshua R Sonett; Mark Ginsburg; Lyall Gorenstein; Charles A Powell
Journal:  Am J Surg Pathol       Date:  2009-03       Impact factor: 6.394

10.  Differential expression of telomerase reverse transcriptase (hTERT) in lung tumours.

Authors:  S Lantuejoul; J C Soria; D Moro-Sibilot; L Morat; S Veyrenc; P Lorimier; P Y Brichon; L Sabatier; C Brambilla; E Brambilla
Journal:  Br J Cancer       Date:  2004-03-22       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.